OptimizeRx Corp - FORM 10-K - EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO - March 26, 2020

Attached files

file filename
10-K - ANNUAL REPORT - OptimizeRx Corpf10k2019_optimizerxcorp.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-2_optimizerx.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECURITIES EXCHANGE ACT RUL - OptimizeRx Corpf10k2019ex31-1_optimizerx.htm
EX-23.1 - CONSENT OF MARCUM LLP - OptimizeRx Corpf10k2019ex23-1_optimizerx.htm
EX-21.1 - LIST OF SUBSIDIARIES - OptimizeRx Corpf10k2019ex21-1_optimizerx.htm
EX-10.6 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH MIRIAM PARAMORE, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-6_optimizerx.htm
EX-10.5 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH STEPHEN SILVESTRO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-5_optimizerx.htm
EX-10.4 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH WILLIAM FEBBO, DATED MARCH, 10, 2020 - OptimizeRx Corpf10k2019ex10-4_optimizerx.htm
EX-10.3 - AMENDMENT TO EMPLOYMENT AGREEMENT WITH DOUG BAKER, DATED MARCH 10, 2020 - OptimizeRx Corpf10k2019ex10-3_optimizerx.htm

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual Report of OptimizeRx Corp (the “Company”) on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission (the “Report”), I, William J. Febbo, Chief Executive Officer of the Company, and I, Douglas P. Baker, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/ William J. Febbo
Name: William J. Febbo
Title: Chief Executive Officer, Principal Executive Officer
Date:

March 26, 2020

 

By: /s/ Doug Baker
Name: Doug Baker
Title: Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Date:

March 26, 2020

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

Stock widget

Investing forum

OptimizeRx Corp Reports